Details of the Drug

General Information of Drug (ID: DMYD8GP)

Drug Name

5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione

Synonyms

CHEMBL41666; 5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione; BDBM50227231; 68475-20-7

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

219.24

Logarithm of the Partition Coefficient (xlogp)

2.1

Rotatable Bond Count (rotbonds)

2

Hydrogen Bond Donor Count (hbonddonor)

0

Hydrogen Bond Acceptor Count (hbondacc)

3

Chemical Identifiers

Formula: C12H13NO3
IUPAC Name: 5-ethyl-3-methyl-5-phenyl-1,3-oxazolidine-2,4-dione
Canonical SMILES: CCC1(C(=O)N(C(=O)O1)C)C2=CC=CC=C2
InChI: InChI=1S/C12H13NO3/c1-3-12(9-7-5-4-6-8-9)10(14)13(2)11(15)16-12/h4-8H,3H2,1-2H3
InChIKey: BWNMMRKYEBCJHN-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Sodium channel unspecific (NaC)	TTRK8B9	NOUNIPROTAC	Inhibitor	[1]
Voltage-gated sodium channel alpha Nav1.3 (SCN3A)	TTAXZ0K	SCN3A_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Sodium channel binding and anticonvulsant activities for the enantiomers of a bicyclic 2,4-oxazolidinedione and monocyclic models. J Med Chem. 1989 Jul;32(7):1577-80.